{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26457673", "DateCompleted": {"Year": "2016", "Month": "06", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "10", "Day": "12"}], "ELocationID": ["e0139761", "10.1371/journal.pone.0139761"], "Language": ["eng"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "10", "Issue": "10", "PubDate": {"Year": "2015"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Clinical Effect of Antioxidant Glasses Containing Extracts of Medicinal Plants in Patients with Dry Eye Disease: A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.", "Pagination": {"StartPage": "e0139761", "MedlinePgn": "e0139761"}, "Abstract": {"AbstractText": ["To investigate the clinical efficacy and safety of wearable antioxidant glasses containing extracts of medicinal plants in patients with mild dry eye disease (DED).", "Fifty patients with mild DED were randomly assigned to wear either extracts of antioxidant medicinal plants containing (N = 25) or placebo glasses (N = 25). Patients wore the glasses for 15 min three times daily. The ocular surface disease index (OSDI) score, tear film break up time (BUT), and Schirmer's test were evaluated and compared within the group and between the groups at baseline, 4 weeks, and 8 weeks after treatment.", "OSDI score and tear film BUT were significantly improved in the treatment group at 4 and 8 weeks after wearing glasses (all P < 0.001). Compared to the placebo group, the OSDI scores were significantly lower in the treatment group at 8 weeks (P = 0.007). The results of the Schirmer's test showed significant improvement in the treatment group at 4 weeks (P = 0.035), however there were no significant differences between the other groups or within the groups. No adverse events were reported during the study.", "Antioxidant glasses containing extracts of medicinal plants were effective in improving in DED both subjectively and objectively. Wearing antioxidants glasses might be a safe and adjunctive therapeutic option for DED.", "ISRCTN registry 71217488."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea."}], "LastName": "Choi", "ForeName": "Won", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea."}], "LastName": "Kim", "ForeName": "Jae Chan", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea."}], "LastName": "Kim", "ForeName": "Won Soo", "Initials": "WS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea."}], "LastName": "Oh", "ForeName": "Han Jin", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea."}], "LastName": "Yang", "ForeName": "Jee Myung", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Chonnam National University Medical School and Hospital, Gwangju, Korea."}], "LastName": "Lee", "ForeName": "Jee Bum", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea."}], "LastName": "Yoon", "ForeName": "Kyung Chul", "Initials": "KC"}], "DataBankList": [{"DataBankName": "ISRCTN", "AccessionNumberList": ["ISRCTN71217488"]}], "PublicationTypeList": ["Journal Article", "Multicenter Study", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Dry Eye Syndromes"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Glass"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "<b>Competing Interests: </b>BM biotechnology provided the antioxidant glasses for this clinical trial. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 2009;3:405\u201312.", "ArticleIdList": ["PMC2720680", "19688028"]}, {"Citation": "Jeong IY, Park YW, Lee SS, Woo JM, Park YG, Yoon KC. Long Term Follow-up Results of Topical 0.05% Cyclosporine A in Patient with Dry Eye. Chonnam Med J 2008;44:151\u20136."}, {"Citation": "Calonge M. The treatment of dry eye. Surv Ophthalmol 2001;45:S227\u201339.", "ArticleIdList": ["11587147"]}, {"Citation": "Dogru M, Wakamatsu T, Kojima T, Matsumoto Y, Kawakita T, Schnider C, et al. The role of oxidative stress and inflammation in dry eye disease. Cornea 2009;28:S70\u20134."}, {"Citation": "Uchino Y, Kawakita T, Ishii T, Ishii N, Tsubota K. A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland. Cornea 2012;31:S63\u20137. 10.1097/ICO.0b013e31826a5de1", "ArticleIdList": ["10.1097/ICO.0b013e31826a5de1", "23038038"]}, {"Citation": "Higuchi A, Takahashi K, Hirashima M, Kawakita T, Tsubota K. Selenoprotein P controls oxidative stress in cornea. PLoS One 2010;5:e9911.", "ArticleIdList": ["PMC2847950", "20360971"]}, {"Citation": "J\u00e4rvinen RL, Larmo PS, Set\u00e4l\u00e4 NL, Yang B, Engblom JR, Viitanen MH, et al. Effects of oral sea buckthorn oil on tear film fatty acids in individuals with dry eye. Cornea 2011;30:1013\u20139. 10.1097/ICO.0b013e3182035ad9", "ArticleIdList": ["10.1097/ICO.0b013e3182035ad9", "21832964"]}, {"Citation": "Cavet ME, Harrington KL, Vollmer TR, Ward KW, Zhang JZ. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Mol Vis 2011;17:533\u201342.", "ArticleIdList": ["PMC3044696", "21364905"]}, {"Citation": "Li Z, Choi JH, Oh HJ, Park SH, Lee JB, Yoon KC. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye. Curr Eye Res 2014;39:871\u20138. 10.3109/02713683.2014.884595", "ArticleIdList": ["10.3109/02713683.2014.884595", "24559509"]}, {"Citation": "Kangari H, Eftekhari MH, Sardari S, Hashemi H, Salamzadeh J, Ghassemi-Broumand M, et al. Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology 2013;120:2191\u20136. 10.1016/j.ophtha.2013.04.006", "ArticleIdList": ["10.1016/j.ophtha.2013.04.006", "23642375"]}, {"Citation": "Lee JE, Kim NM, Yang JW, Kim SJ, Lee JS, Lee JE. A randomised controlled trial comparing a thermal massager with artificial teardrops for the treatment of dry eye. Br J Ophthalmol 2014;98:46\u201351. 10.1136/bjophthalmol-2013-303742", "ArticleIdList": ["10.1136/bjophthalmol-2013-303742", "24133024"]}, {"Citation": "Lee JB, Kim SH, Lee SC, Kim HG, Ahn HG, Li Z, et al. Blue light-induced oxidative stress in human corneal epithelial cells: protective effects of ethanol extracts of various medicinal plant mixtures. Invest Ophthalmol Vis Sci 2014;55:4119\u201327. 10.1167/iovs.13-13441", "ArticleIdList": ["10.1167/iovs.13-13441", "24925877"]}, {"Citation": "Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000;118:615\u201321.", "ArticleIdList": ["10815152"]}, {"Citation": "Yoon KC, Im SK, Kim HG, You IC. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome. Cornea 2011;30:972\u20136. 10.1097/ICO.0b013e31820687dd", "ArticleIdList": ["10.1097/ICO.0b013e31820687dd", "21705877"]}, {"Citation": "Yoon KC, Im SK, Park YG, Jung YD, Yang SY, Choi J. Application of umbilical cord serum eye drops for the treatment of dry eye syndrome. Cornea 2006;25:268\u201372.", "ArticleIdList": ["16633024"]}, {"Citation": "Jeon JH1, Shin MS, Lee MS, Jeong SY, Kang KW, Kim YI, et al. Acupuncture reduces symptoms of dry eye syndrome: a preliminary observational study. J Altern Complement Med. 2010;16:1291\u20134. 10.1089/acm.2009.0537", "ArticleIdList": ["10.1089/acm.2009.0537", "21138389"]}, {"Citation": "Augustin AJ, Spitznas M, Kaviani N, Meller D, Koch FH, Grus F, et al. Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Arch Clin Exp Ophthalmol 1995;233:694\u20138.", "ArticleIdList": ["8566825"]}, {"Citation": "Nakamura S, Shibuya M, Nakashima H, Hisamura R, Masuda N, Imagawa T, et al. Involvement of oxidative stress on corneal epithelial alterations in a blinksuppressed dry eye. Invest Ophthalmol Vis Sci 2007;48:1552\u20138.", "ArticleIdList": ["17389484"]}, {"Citation": "Wakamatsu TH, Dogru M, Matsumoto Y, Kojima T, Kaido M, Ibrahim OM, et al. Evaluation of lipid oxidative stress status in Sj\u00f6gren syndrome patients. Invest Ophthalmol Vis Sci 2013;54:201\u201310. 10.1167/iovs.12-10325", "ArticleIdList": ["10.1167/iovs.12-10325", "23150615"]}, {"Citation": "Kim EC, Choi JS, Joo CK. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Am J Ophthalmol 2009;147:206\u201313. 10.1016/j.ajo.2008.08.015", "ArticleIdList": ["10.1016/j.ajo.2008.08.015", "18848318"]}, {"Citation": "Drouault-Holowacz S, Bieuvelet S, Burckel A, Rigal D, Dubray C, Lichon JL, et al. Antioxidants intake and dry eye syndrome: a crossover, placebo-controlled, randomized trial. Eur J Ophthalmol 2009;19:337\u201342.", "ArticleIdList": ["19396775"]}, {"Citation": "Blades KJ, Patel S, Aidoo KE. Oral antioxidant therapy for marginal dry eye. Eur J Clin Nutr 2001;55:589\u201397.", "ArticleIdList": ["11464232"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "7", "Day": "21"}, {"Year": "2015", "Month": "9", "Day": "8"}, {"Year": "2015", "Month": "10", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "10", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "10", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["26457673", "PMC4601690", "10.1371/journal.pone.0139761", "PONE-D-15-30652"]}}], "PubmedBookArticle": []}